Patents by Inventor Arlan Richardson

Arlan Richardson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20220096446
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: December 2, 2021
    Publication date: March 31, 2022
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • Use of mTOR inhibitors for treatment of familial adenomatous polyposis
    Patent number: 11191750
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: December 7, 2021
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Zelton Dave Sharp, Randy Strong, Paul Hasty, Carolina Livi, Arlan Richardson
  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20200330442
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: June 29, 2020
    Publication date: October 22, 2020
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20170105974
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: October 28, 2016
    Publication date: April 20, 2017
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20160030401
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • USE OF INHIBITORS OF MTOR TO IMPROVE VASCULAR FUNCTIONS IN APOE4 CARRIERS
    Publication number: 20160022649
    Abstract: Disclosed are methods and compositions for preventing cerebrovascular function dysfunction in a patient who has been identified as an ApoE4 carrier. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Ai-Ling LIN, Arlan RICHARDSON, Veronica GALVAN, Peter FOX, Steven AUSTAD, Kathleen FISCHER
  • USE OF MTOR INHIBITORS TO TREAT VASCULAR COGNITIVE IMPAIRMENT
    Publication number: 20150290176
    Abstract: Disclosed are methods and compositions for the treatment or prevention of vascular cognitive impairment. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: October 11, 2013
    Publication date: October 15, 2015
    Inventors: Arlan Richardson, Veronica Galvan, Ai-Ling Lin, Peter Fox, Dana M. Vaughn